MultiTAA-specific T cells

BIOLOGICAL2 trials

Sponsors

Baylor College of Medicine

Conditions

Acute Myeloid LeukemiaLeukemia, Lymphoblastic (Acute)Myelodysplastic Syndrome

Phase 1

Administration of Donor MultiTAA-Specific T Cells for ALL

CompletedNCT02475707

Baylor College of MedicineLeukemia, Lymphoblastic (Acute)

Start: 2016-02-29End: 2024-11-18Updated: 2024-12-06

Administration of Donor Multi TAA-Specific T Cells for AML or MDS (ADSPAM)

CompletedNCT02494167

Baylor College of MedicineAcute Myeloid Leukemia, Myelodysplastic Syndrome

Start: 2016-02-01End: 2026-06-01Updated: 2026-08-26

Related Papers

Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant

Blood2020-12-0363 citations